NXGL
HEALTHCARENexgel Inc
AI Insight
What's Moving NXGL Today?
No stock-specific AI insight has been generated for NXGL yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.48$2.89
$0.56
Fundamentals
Market Cap$5M
P/E Ratio—
EPS$-0.40
Dividend Yield—
Dividend / Share—
ROE-61.4%
Profit Margin-28.5%
Debt / Equity—
Trading
Volume1.4M
Avg Volume (10D)—
Shares Outstanding9.2M
NXGL News
25 articles- Insider sale: NEXGEL (NXGL) CEO sells 11,000 common sharesStock Titan·Jun 23, 2026
- [Form 4] NEXGEL, INC. Insider Trading ActivityStock Titan·Jun 10, 2026
- NEXGEL to Present at Planet MicroCap Conference Las Vegas on June 16th –18thYahoo Finance·Jun 4, 2026
- NexGel Inc stock (US65340W1027): shares hover near 52-week lows as investors await fresh catalystsAd Hoc News·Jun 1, 2026
- NEXGEL (NASDAQ: NXGL) CEO Adam R. Levy sells 13,000 shares in open market tradesStock Titan·May 30, 2026
- NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume ConcentrationYahoo Finance·May 19, 2026
- NexGel Inc stock (US65340W1027): Q1 2026 numbers put hydrogel growth story in focusAD HOC NEWS·May 17, 2026
- Nexgel (NXGL) Q1 2026 Earnings TranscriptMotley Fool·May 15, 2026
- NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX SurgicalYahoo Finance·May 13, 2026
- NEXGEL To Report First Quarter 2026 Financial Results on May 15thYahoo Finance·May 12, 2026
- NEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience™, to Board of DirectorsYahoo Finance·May 6, 2026
- NEXGEL Appoints Ian Blackman as Chief Financial OfficerYahoo Finance·Apr 27, 2026
- NEXGEL New Strategic Partner, Sequence LifeScience™, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease SegmentYahoo Finance·Apr 21, 2026
- Celularity Announces Closing of Transaction with NexGelYahoo Finance·Apr 21, 2026
- NEXGEL, Inc. Q4 2025 Earnings Call SummaryMoby·Apr 21, 2026
- NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ETGlobeNewswire Inc.·Apr 17, 2026
- NEXGEL Reschedules Shareholder Update Conference Call to April 23rd at 4:30 P.M. ET to Provide Update on Celularity TransactionYahoo Finance·Apr 15, 2026
- NexGel Inc (NXGL) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Operational ...Yahoo Finance·Apr 9, 2026
- NEXGEL Reschedules Shareholder Update Conference Call to April 15th at 4:30 P.M. ET to Provide Update on Celularity TransactionYahoo Finance·Apr 8, 2026
- NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with CelularityYahoo Finance·Mar 31, 2026
- NEXGEL to Report Fourth Quarter and Full Year 2025 Financial Results on March 31stYahoo Finance·Mar 25, 2026
- NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial ProductsYahoo Finance·Mar 12, 2026
- Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product OpportunitiesYahoo Finance·Mar 12, 2026
- NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-Stage Regenerative Biomaterial ProductsYahoo Finance·Mar 10, 2026
- NEXGEL Announces Financing of $1.797 Million Relating to an Acquisition Targeted to Close in the First Quarter of 2026, Subject to the Completion of Due DiligenceYahoo Finance·Feb 10, 2026
All 25 articles loaded
Price Data
Open$0.60
Previous Close$0.61
Day High$0.62
Day Low$0.54
52 Week High$2.89
52 Week Low$0.48
52-Week Range
$0.48$2.89
$0.56
Fundamentals
Market Cap$5M
P/E Ratio—
EPS$-0.40
Dividend Yield—
Dividend / Share—
ROE-61.4%
Profit Margin-28.5%
Debt / Equity—
Trading
Volume1.4M
Avg Volume (10D)—
Shares Outstanding9.2M
About Nexgel Inc
NEXGEL, Inc. manufactures aqueous, electron beam crosslinked, high water content hydrogels and polymeric gels. The company is headquartered in Langhorne, Pennsylvania.
HEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL INSTRUMENTS & SUPPLIES
CIK—
Composite FIGI—
Share Class FIGI—